Medicamen Biotech Limited
NSE: MEDICAMEQ.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Rajesh Madan Pharma
- Employees
- 378
- Headquarters
- New Delhi, India
- IPO year
- 2021
- Market cap
- ₹4.0B
- Website
- https://www.medicamen.com
Loading MEDICAMEQ…
Loading profile data…Frequently asked questions about MEDICAMEQ
What does Medicamen Biotech Limited (MEDICAMEQ.NS) do?
Medicamen Biotech Limited manufactures and sells pharmaceutical formulations in India. The company offers its products in various forms, including tablets, capsules, liquid and dry syrups, and ointments. It also provides oral rehydration solution, mouth wash, and dental care products. The company was incorporated in 1993 and is based in New Delh...
Where does MEDICAMEQ.NS trade?
Medicamen Biotech Limited (MEDICAMEQ.NS) trades on the National Stock Exchange of India.
What sector is MEDICAMEQ.NS in?
Medicamen Biotech Limited (MEDICAMEQ.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Medicamen Biotech Limited?
Rajesh Madan Pharma is the chief executive officer of Medicamen Biotech Limited (MEDICAMEQ.NS).
Where is Medicamen Biotech Limited headquartered?
Medicamen Biotech Limited is headquartered in India.
Does MEDICAMEQ.NS pay a dividend?
Yes — Medicamen Biotech Limited (MEDICAMEQ.NS) paid a trailing twelve-month dividend of INR 1.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did MEDICAMEQ.NS go public?
Medicamen Biotech Limited (MEDICAMEQ.NS) completed its initial public offering in 2021.